| 摘要 |
PROBLEM TO BE SOLVED: To provide further therapies that allow effective treatments of mammals, in particular humans, with ET-743, while reducing or eliminating its toxic side effects and minimizing further adverse effects. SOLUTION: This invention relates to combination products, combination drug treatments and methods for treating patients afflicted with cancer, having fewer and less severe unwanted toxic effects. According to one aspect, the invention provides a method of treating the human body for cancer comprising administering an effective therapeutic amount of a Pegylated Liposomal form of anthracycline Doxorubicin (PLD), in combination with an effective therapeutic amount of ET-743. COPYRIGHT: (C)2010,JPO&INPIT
|
